Abatacept - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
Product details |
Supply Impact Dates |
Further Details |
ORENCIA abatacept (rch) 125 mg single dose syringe subcutaneous injection ultrasafe passive needle guard and flange extender AUST R: 206764Active ingredients:
Abatacept
Dosage form: Injection
Sponsor: Bristol-Myers Squibb Australia Pty Ltd
Phone: 1800 067 567
|
From 08 May 2024 to 27 Aug 2024
|
Shortage status: Resolved
Availability: Available
Reason: Unexpected increase in consumer demand
|